NCT00003398View on ClinicalTrials.gov

Bone Marrow Transplantation in Treating Patients With Hematologic Cancer

PHASE4CompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

September 30, 1998

Primary Completion Date

May 31, 2000

Study Completion Date

May 31, 2000

Conditions
AnemiaGraft Versus Host DiseaseLeukemiaLymphomaMultiple Myeloma and Plasma Cell NeoplasmMyelodysplastic Syndromes
Interventions
BIOLOGICAL

anti-thymocyte globulin

BIOLOGICAL

filgrastim

DRUG

cyclophosphamide

DRUG

thiotepa

PROCEDURE

allogeneic bone marrow transplantation

PROCEDURE

bone marrow ablation with stem cell support

RADIATION

radiation therapy

Trial Locations (1)

21201

Marlene & Stewart Greenebaum Cancer Center, University of Maryland, Baltimore

All Listed Sponsors
collaborator

University of Maryland Greenebaum Cancer Center

OTHER

lead

University of Maryland, Baltimore

OTHER

NCT00003398 - Bone Marrow Transplantation in Treating Patients With Hematologic Cancer | Biotech Hunter | Biotech Hunter